Paclitaxel: all 2,138 studies that test it

Page 6 of 22. Open to participants first (342), then studies with results posted, then the rest; newest registration first within each.

• A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerTerminatedNCT02389985Phase 1/2Results posted
• Fasting on Newly Diagnosed Breast CancerTerminatedNCT02379585Phase 1/2Results posted
• BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast CancerCompletedNCT02379247Phase 1/2Results posted
• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]CompletedNCT02367794Phase 3Results posted
• Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid TumorsTerminatedNCT02367352Phase 1Results posted
• Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid TumoursCompletedNCT02341456Phase 1Results posted
• LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL CancerCompletedNCT02328105Phase 2Results posted
• A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesCompletedNCT02327169Phase 1Results posted
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has SpreadTerminatedNCT02322814Phase 2Results posted
• Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal CancerCompletedNCT02317991Phase 2Results posted
• Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast CancerActive, not recruitingNCT02315196Phase 2Results posted
• Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT02312245Phase 2Results posted
• Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based ChemotherapyCompletedNCT02303977Phase 2Results posted
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)CompletedNCT02301143Phase 2Results posted
• Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular CharacteristicsTerminatedNCT02297230Phase 1/2Results posted
• Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT02289898Phase 2Results posted
• Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2CompletedNCT02289456Phase 2Results posted
• Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic ResponseCompletedNCT02280252Phase 2Results posted
• Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal CancerCompletedNCT02258659Phase 2Results posted
• Evaluation of Votrient in AngiosarcomaTerminatedNCT02212015Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02194829Phase 1/2Results posted
• Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With CholangiocarcinomaCompletedNCT02181634Phase 2Results posted
• Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic CancerCompletedNCT02178436Phase 1/2Results posted
• Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT02158520Phase 2Results posted
• Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid CancerCompletedNCT02152137Phase 2Results posted
• Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the ElderlyCompletedNCT02151149Phase 4Results posted
• Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHNCompletedNCT02124707Phase 2Results posted
• Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine CancerTerminatedNCT02112552Phase 2Results posted
• Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxelCompletedNCT02106884Phase 2Results posted
• Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal CancerCompletedNCT02103062Phase 2Results posted
• Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerCompletedNCT02077881Phase 1/2Results posted
• Treatment With Nab-paclitaxel in Cutaneous SCCTerminatedNCT02076243Phase 2Results posted
• Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple MyelomaTerminatedNCT02075021Phase 1/2Results posted
• PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung CancerCompletedNCT02073968Phase 2Results posted
• Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With PaclitaxelCompletedNCT02073487Phase 2Results posted
• Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic CancerTerminatedNCT02047500Phase 1Results posted
• Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast CancerSuspendedNCT02037529Phase 3Results posted
• Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.CompletedNCT02033993Phase 2Results posted
• Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerCompletedNCT02027428Phase 3Results posted
• Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic CancerCompletedNCT02017015Phase 2Results posted
• A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast CancerCompletedNCT02015676Phase 1/2Results posted
• Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)CompletedNCT02001974Phase 1Results posted
• Cisplatin vs Paclitaxel for Triple Negative Breast CancerCompletedNCT01982448Phase 2Results posted
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)CompletedNCT01964430Phase 3Results posted
• Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT01962948Phase 1/2Results posted
• Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsCompletedNCT01962103Phase 1/2Results posted
• BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid TumorsCompletedNCT01938846Phase 1Results posted
• Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerTerminatedNCT01938833Phase 1/2Results posted
• Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast CancerTerminatedNCT01897441Not applicableResults posted
• Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDACompletedNCT01893801Phase 1/2Results posted
• Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast CancerTerminatedNCT01891357Phase 2Results posted
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)CompletedNCT01881230Phase 2/3Results posted
• Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway SignalingCompletedNCT01868022Phase 1Results posted
• Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid TumorsCompletedNCT01862328Phase 1Results posted
• Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast CancerCompletedNCT01855828Phase 2Results posted
• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)CompletedNCT01853748Phase 2Results posted
• Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic CancerTerminatedNCT01851174Phase 2Results posted
• A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic AdenocarcinomaCompletedNCT01839799Phase 2Results posted
• Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid TumorsCompletedNCT01831089Phase 1Results posted
• Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast CancerCompletedNCT01827163Phase 2Results posted
• Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic MelanomaCompletedNCT01827111Phase 2Results posted
• An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid TumorsTerminatedNCT01822756Phase 1Results posted
• Abraxane/BevacizumabTerminatedNCT01821859Phase 2Results posted
• Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCaCompletedNCT01796197Phase 2Results posted
• A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer PatientsCompletedNCT01764022Phase 3Results posted
• A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung CancerCompletedNCT01763645Phase 3Results posted
• Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLCCompletedNCT01757288Phase 1/2Results posted
• Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast CancerCompletedNCT01750073Phase 2Results posted
• Schedules of Nab-Paclitaxel in Metastatic Breast CancerCompletedNCT01746225Phase 2Results posted
• A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.TerminatedNCT01732640Phase 1/2Results posted
• Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerCompletedNCT01730833Phase 2Results posted
• Abraxane in CIMP-High Colorectal and Small Bowel AdenocarcinomasCompletedNCT01730586Phase 2Results posted
• Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01716715Phase 2Results posted
• Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002)CompletedNCT01704287Phase 2Results posted
• Single Arm on the Tolerability of Weekly Nab-paclitaxelCompletedNCT01702844Phase 2Results posted
• Endoscopic Abraxane Injection Into Pancreatic CystsTerminatedNCT01698710Not applicableResults posted
• Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast CancerCompletedNCT01688609Phase 2Results posted
• Dose-finding Study in Platinum-Resistant Ovarian CancerCompletedNCT01653912Phase 1/2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT01646762Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung CancerCompletedNCT01620190Phase 2Results posted
• Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral SurgeryCompletedNCT01612351Phase 2Results posted
• Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2CompletedNCT01593020Phase 2Results posted
• Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric CancerTerminatedNCT01579578Phase 2Results posted
• Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck CancerCompletedNCT01566435Phase 2Results posted
• Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast CancerCompletedNCT01565499Phase 2Results posted
• Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate CancerTerminatedNCT01558492Phase 2Results posted
• Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerCompletedNCT01547741Phase 3Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerActive, not recruitingNCT01525966Phase 2Results posted
• Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid TumorsCompletedNCT01525602Phase 1Results posted
• Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric CancerCompletedNCT01522768Phase 2Results posted
• A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid TumorsCompletedNCT01515306Phase 2Results posted
• Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerCompletedNCT01506609Phase 2Results posted
• Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic AdenocarcinomaCompletedNCT01470417Phase 2Results posted
• Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT01463072Phase 2Results posted
• Effects of Paclitaxel on Intimal HyperplasiaCompletedNCT01454778Not applicableResults posted
• Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)CompletedNCT01454102Phase 1Results posted
• Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)CompletedNCT01446016Phase 2Results posted
• Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical CancerCompletedNCT01414608Phase 3Results posted
• Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT01412229Phase 2Results posted
• Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ)TerminatedNCT01395537Phase 1/2Results posted

← Paclitaxel overview